NaviFUS Corp. (TPEX:6872)
Taiwan · Delayed Price · Currency is TWD 20.30
+0.15 (0.74%)
Jul 18, 2025, 1:30 PM CST
NaviFUS Company Description
NaviFUS Corp., a medical device company, develops and sells focused ultrasound (FUS) solutions for the unmet needs in neuromedicine in Taiwan.
The company develops NaviFUS, a neuronavigator-guided transcranial FUS system that delivers focal energy into deep tissues in the brain, as well as is used in various clinical applications, such as drug delivery, neuromodulation, immuno-stimulation, and others.
It also develops NAVIRFA, a navigation system that uses optical 3D surgical tracking technology to monitor the 3D position of the needle tip during ultrasonic interventional procedures.
The company was founded in 2015 and is based in Taipei, Taiwan.
NaviFUS Corp.
| Country | Taiwan |
| Founded | 2015 |
| Industry | Biotechnology |
| Sector | Healthcare |
| CEO | Arthur Lung |
Contact Details
Address: No. 246, Chengde Rd. Taipei, 103 Taiwan | |
| Phone | 886 2 2586 0560 |
| Website | navifus.com |
Stock Details
| Ticker Symbol | 6872 |
| Exchange | Taipei Exchange |
| Stock Type | Common Stock |
| Reporting Currency | TWD |
| ISIN Number | TW0006872005 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Dr. Arthur Lung Ph.D. | Chief Executive Officer |
| Dr. Hao-Li Liu Ph.D. | Founder and Chief Technical Consultant |